DOT1L and neoplasm: The aberrant expression of DOT1L is thought to be correlated with an increased proliferative rate, augmented metastatic capacity, and unfavorable outcomes in several tumor types [42, 43], even though the knockdown and overexpression of DOT1L alone have no apparent effect on colony formation or apoptotic assays in our present results.